Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNFgene. GDNF is a small protein that potently promotes the survival of many types of neurons.
This gene encodes a highly conserved neurotrophic factor. The recombinant form of this protein was shown to promote the survival and differentiation of dopaminergic neurons in culture, and was able to prevent apoptosis of motor neurons induced by axotomy. The encoded protein is processed to a mature secreted form that exists as a homodimer. The mature form of the protein is a ligand for the product of the RET (rearranged during transfection) protooncogene. In addition to the transcript encoding GDNF, two additional alternative transcripts encoding distinct proteins, referred to as astrocyte-derived trophic factors, have also been described. Mutations in this gene may be associated with Hirschsprung's disease.
GDNF has regenerative properties for brain cells and showed potential as treatment for Parkinson's disease - monkeys with an induced form of Parkinson's disease showed less trembling when treated with the drug, and neuronal fibres grew in part of the human brain exposed to the drug. However progress to a treatment is hampered by the problem of delivering the drug to brain cells through the blood-brain barrier in human.
^Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D (June 2008). "GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse". Proc. Natl. Acad. Sci. U.S.A.105 (23): 8114–9. doi:10.1073/pnas.0711755105. PMC2423415. PMID18541917.
^ abJing, S; Yu Y, Fang M, Hu Z, Holst P L, Boone T, Delaney J, Schultz H, Zhou R, Fox G M (December 1997). "GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family". J. Biol. Chem. (UNITED STATES) 272 (52): 33111–7. doi:10.1074/jbc.272.52.33111. ISSN0021-9258. PMID9407096.
^ abCik, M; Masure S, Lesage A S, Van Der Linden I, Van Gompel P, Pangalos M N, Gordon R D, Leysen J E (September 2000). "Binding of GDNF and neurturin to human GDNF family receptor alpha 1 and 2. Influence of cRET and cooperative interactions". J. Biol. Chem. (UNITED STATES) 275 (36): 27505–12. doi:10.1074/jbc.M000306200. ISSN0021-9258. PMID10829012.
Schindelhauer D, Schuffenhauer S, Gasser T, et al. (1996). "The gene coding for glial cell line derived neurotrophic factor (GDNF) maps to chromosome 5p12-p13.1.". Genomics28 (3): 605–7. doi:10.1006/geno.1995.1202. PMID7490108.
Tomac A, Lindqvist E, Lin LF, et al. (1995). "Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.". Nature373 (6512): 335–9. doi:10.1038/373335a0. PMID7830766.
Oppenheim RW, Houenou LJ, Johnson JE, et al. (1995). "Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF.". Nature373 (6512): 344–6. doi:10.1038/373344a0. PMID7830769.
Schaar DG, Sieber BA, Sherwood AC, et al. (1995). "Multiple astrocyte transcripts encode nigral trophic factors in rat and human.". Exp. Neurol.130 (2): 387–93. doi:10.1006/exnr.1994.1218. PMID7867768.
Lin LF, Doherty DH, Lile JD, et al. (1993). "GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.". Science260 (5111): 1130–2. doi:10.1126/science.8493557. PMID8493557.
Bermingham N, Hillermann R, Gilmour F, et al. (1996). "Human glial cell line-derived neurotrophic factor (GDNF) maps to chromosome 5.". Hum. Genet.96 (6): 671–3. doi:10.1007/BF00210297. PMID8522325.
Gash DM, Zhang Z, Ovadia A, et al. (1996). "Functional recovery in parkinsonian monkeys treated with GDNF.". Nature380 (6571): 252–5. doi:10.1038/380252a0. PMID8637574.
Jing S, Wen D, Yu Y, et al. (1996). "GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.". Cell85 (7): 1113–24. doi:10.1016/S0092-8674(00)81311-2. PMID8674117.
Angrist M, Bolk S, Halushka M, et al. (1996). "Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.". Nat. Genet.14 (3): 341–4. doi:10.1038/ng1196-341. PMID8896568.
Salomon R, Attié T, Pelet A, et al. (1996). "Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.". Nat. Genet.14 (3): 345–7. doi:10.1038/ng1196-345. PMID8896569.
Ivanchuk SM, Myers SM, Eng C, Mulligan LM (1997). "De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.". Hum. Mol. Genet.5 (12): 2023–6. doi:10.1093/hmg/5.12.2023. PMID8968758.
Haniu M, Hui J, Young Y, et al. (1997). "Glial cell line-derived neurotrophic factor: selective reduction of the intermolecular disulfide linkage and characterization of its disulfide structure.". Biochemistry35 (51): 16799–805. doi:10.1021/bi9605550. PMID8988018.
Bär KJ, Facer P, Williams NS, et al. (1997). "Glial-derived neurotrophic factor in human adult and fetal intestine and in Hirschsprung's disease.". Gastroenterology112 (4): 1381–5. doi:10.1016/S0016-5085(97)70154-9. PMID9098026.
Jing S, Yu Y, Fang M, et al. (1998). "GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family.". J. Biol. Chem.272 (52): 33111–7. doi:10.1074/jbc.272.52.33111. PMID9407096.
Eng C, Myers SM, Kogon MD, et al. (1998). "Genomic structure and chromosomal localization of the human GDNFR-alpha gene.". Oncogene16 (5): 597–601. doi:10.1038/sj.onc.1201573. PMID9482105.